Timeline
Nanoco
Glass Lewis backs Nanoco's delisting proposal
Nanoco Group shares crashed after delisting proposal
Nanoco Group posts £7.7m H1 revenue after $5m LG licence
More in Hardware & Electronics
Shield Therapeutics takes full US control of ACCRUFeR
The iron deficiency specialist will absorb its co-commercialisation partner's sales force and retain all US gross profit from ACCRUFeR, paying Viatris a royalty instead of a profit share.